Skip to main content

Animations

MJFF Publications

8151 - 8160 of 8587 Results
Title
Year
  • Year
  • 2024
  • 2025
  • 2022
  • 2021
  • 2019
  • 2019
  • 2022
  • 2015
  • 2024
  • 2003
  • Summary Details
    OPEN
    Title: Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29925
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115636
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/pro.4360
    Citation Count: 9
  • Summary Details
    OPEN
    Title: T lymphocyte senescence is attenuated in Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-021-02287-9
    Citation Count: 31
  • Summary Details
    RESTRICTED
    Title: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Higher urate in LRRK2 mutation carriers resistant to Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25436
    Best OA location URL:
    Citation Count: 52
  • Summary Details
    RESTRICTED
    Title: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29058
    Best OA location URL:
    Citation Count: 17
  • Summary Details
    OPEN
    Title: 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddv453
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Toward the quantification of α-synuclein aggregates with digital seed amplification assays
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2312031121
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Pitx3 is required for development of substantia nigra dopaminergic neurons
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0230529100
    Citation Count: 382
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.